Johnson & Johnson's Fiscal Year is From January To December.
The item "Price-Earnings-Ratio" stands at 17.38 as of 09/30/2025, the lowest value since 09/30/2024.
As of the end of Johnson & Johnson's third quarter, the item "Price Earnings Ratio" stands at 17.38. This represents a decrease of -6.33 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -33.21 percent compared to the value the year prior.
The 1 year change in percent is -33.21.
The 3 year change in percent is -10.30.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price Earnings Ratio | 905,699,262,464.00 |
![]() | AbbVie Inc - Price Earnings Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price Earnings Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price Earnings Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Price Earnings Ratio | 255,096,620,580.91 |